Credit Suisse’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,553
Closed -$140K 3127
2023
Q3
$140K Sell
30,553
-1,644
-5% -$15.7K ﹤0.01% 3071
2023
Q2
$360K Buy
32,197
+8,089
+34% +$86.1K ﹤0.01% 2941
2023
Q1
$273K Buy
24,108
+2,785
+13% +$29.6K ﹤0.01% 3030
2022
Q4
$146K Sell
21,323
-21,127
-50% -$202K ﹤0.01% 3257
2022
Q3
$382K Buy
+42,450
New +$369K ﹤0.01% 2954

Other funds holding PROK

Credit Suisse's PROK Position: Q4 2023 in Review

Credit Suisse sold out of ProKidney (PROK) in Q4 2023, closing a stake of 30,553 shares — an estimated $140K sold.

Credit Suisse first reported a position in PROK in Q3 2022 and held it in 5 quarters. The position peaked at $382K in Q3 2022. 61 funds tracked by Wall St. Rank hold PROK as of Q4 2023.

  • Credit Suisse reported no remaining ProKidney position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 30,553 ProKidney shares in Q4 2023, an estimated $140K.
  • Credit Suisse first reported a position in ProKidney in Q3 2022 and held it in 5 quarters.
  • Credit Suisse's ProKidney position peaked at $382K in Q3 2022.
  • 61 funds tracked by Wall St. Rank held ProKidney as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.